Analogic (NASDAQ:ALOG) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of $2.75-2.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.81. The company issued revenue guidance of $450-460 million, compared to the consensus revenue estimate of $452.00 million.

A number of analysts have issued reports on the company. Zacks Investment Research raised Analogic from a hold rating to a buy rating and set a $93.00 target price for the company in a research note on Tuesday, October 10th. Jefferies Group reaffirmed a hold rating and issued a $75.00 target price on shares of Analogic in a research note on Wednesday, September 20th. Four equities research analysts have rated the stock with a hold rating, Analogic presently has an average rating of Hold and an average price target of $85.25.

Shares of Analogic (NASDAQ:ALOG) traded down $0.55 during trading hours on Wednesday, hitting $81.05. The company had a trading volume of 47,300 shares, compared to its average volume of 94,605. The firm has a market cap of $1,018.75, a P/E ratio of 48.57, a price-to-earnings-growth ratio of 4.16 and a beta of 0.86. Analogic has a 1 year low of $66.00 and a 1 year high of $91.40.

Analogic (NASDAQ:ALOG) last issued its quarterly earnings data on Wednesday, December 6th. The medical research company reported $0.75 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.32. The firm had revenue of $106.90 million during the quarter, compared to the consensus estimate of $100.55 million. Analogic had a positive return on equity of 4.27% and a negative net margin of 15.27%. The company’s quarterly revenue was down 11.7% on a year-over-year basis. During the same period last year, the company earned $0.43 EPS. equities analysts predict that Analogic will post 2.8 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Analogic (ALOG) Issues FY18 Earnings Guidance” was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/12/06/analogic-alog-issues-fy18-earnings-guidance.html.

Analogic Company Profile

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Earnings History and Estimates for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Co. and related companies with MarketBeat.com's FREE daily email newsletter.